About Humaneva Group
Humaneva Group is a company based in Raleigh (United States) founded in 2014 by Tomasz Dabrowski and Karolina Sztajerwald Prokopowicz. Humaneva Group has raised $50 million across 1 funding round from investors including Viking Global Investors. Humaneva Group operates in a competitive market with competitors including Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Prudentia Sciences, among others.
- Headquarter Raleigh, United States
- Founders Tomasz Dabrowski, Karolina Sztajerwald Prokopowicz
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Humaneva Spółka Akcyjna
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$50 M (USD)
in 1 rounds
-
Latest Funding Round
$50 M (USD), Private Equity Round
Sep 24, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Humaneva Group
Humaneva Group has successfully raised a total of $50M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $50 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Humaneva Group
Humaneva Group has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Viking Global Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Humaneva Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Humaneva Group
Investment portfolio details for Humaneva Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Humaneva Group
Detailed financials for Humaneva Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Humaneva Group Comparisons
Peer comparison for Humaneva Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Humaneva Group
Humaneva Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Prudentia Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal genomics is applied to healthcare advancements by Fauna Bio.
|
|
| Locked | Locked | Locked |
Data analytics and validation software for regulatory submission in the healthcare sector
|
|
| Locked | Locked | Locked |
AI-based drug discovery and clinical services are provided for biopharma.
|
|
| Locked | Locked | Locked |
AI-powered platforms for autonomous scientific research are developed.
|
|
| Locked | Locked | Locked |
AI-powered diligence and valuation for drug assets are provided.
|
Detailed competitors of Humaneva Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Humaneva Group
Complete news archive for Humaneva Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Humaneva Group
Humaneva Group was founded in 2014 and raised its 1st funding round 10 years after it was founded.
Humaneva Group is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Tomasz Dabrowski is the current CEO of Humaneva Group. They have also founded this company.
Humaneva Group is a funded company, having raised a total of $50M across 1 funding round to date.
Humaneva Group was founded in 2014 and is headquartered in Raleigh, United States. Clinical research data services are offered by the company, focusing on oncology and various other therapeutic areas. Operations encompass data management and analysis for clinical trials, supporting pharmaceutical and biotech sectors. Expertise is applied across multiple geographies through partnerships, with leadership provided by co-founders Tomasz Dabrowski as CEO and Karolina Sztajerwald Prokopowicz.
Humaneva Group's top competitors include Fauna Bio, Predxbio and Lila Sciences.
Humaneva Group has 1 investor. Key investors include Viking Global Investors.